Susquehanna International Group, LLP Alector, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Alector, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 76,540 shares of ALEC stock, worth $311,517. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,540

Previous 20,692 269.9%

Holding current value

$311,517

Previous $93,000 283.87%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.34 - $6.58 $242,380 - $367,479	55,848 Added 269.9%	76,540 $357,000
Q2 2024 Aug 15, 2024	SELL	$4.19 - $6.23 $117,881 - $175,274	-28,134 Reduced 57.62%	20,692 $93,000
Q1 2024 May 07, 2024	SELL	$5.69 - $8.08 $172,856 - $245,462	-30,379 Reduced 38.35%	48,826 $293,000
Q4 2023 Feb 14, 2024	SELL	$3.77 - $8.39 $14,948 - $33,266	-3,965 Reduced 4.77%	79,205 $632,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $176,207 - $297,180	33,886 Added 68.76%	83,170 $538,000
Q2 2023 Aug 11, 2023	SELL	$5.86 - $7.93 $607,869 - $822,594	-103,732 Reduced 67.79%	49,284 $296,000
Q1 2023 May 16, 2023	BUY	$5.85 - $9.84 $541,979 - $911,636	92,646 Added 153.46%	153,016 $947,000
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $926,570 - $1.29 Million	-134,676 Reduced 69.05%	60,370 $557,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $1.46 Million - $2.35 Million	177,667 Added 1022.31%	195,046 $1.85 Million
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $384,328 - $715,403	-50,239 Reduced 74.3%	17,379 $177,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $1.47 Million - $2.35 Million	-112,864 Reduced 62.53%	67,618 $964,000
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $1.23 Million - $1.62 Million	63,415 Added 54.17%	180,482 $3.73 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $89,869 - $163,922	4,151 Added 3.68%	117,067 $2.67 Million
Q2 2021 Aug 11, 2021	BUY	$15.5 - $22.48 $511,531 - $741,884	33,002 Added 41.3%	112,916 $2.35 Million
Q1 2021 May 17, 2021	BUY	$14.84 - $22.23 $190,753 - $285,744	12,854 Added 19.17%	79,914 $1.61 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $720,472 - $1.28 Million	-76,646 Reduced 53.34%	67,060 $1.02 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $1.37 Million - $3.24 Million	129,648 Added 922.24%	143,706 $1.51 Million
Q2 2020 Aug 14, 2020	SELL	$21.87 - $33.11 $981,897 - $1.49 Million	-44,897 Reduced 76.15%	14,058 $344,000
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $958,018 - $2.08 Million	58,955 New	58,955 $1.42 Million
Q4 2019 Feb 14, 2020	SELL	$14.17 - $20.3 $289,733 - $415,074	-20,447 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $294,845 - $453,923	20,447 New	20,447 $295,000

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $336M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Alector, Inc. Transaction History